Attached files
| file | filename |
|---|---|
| 10-K - 10-K - F-star Therapeutics, Inc. | sbph-10k_20171231.htm |
| EX-32.1 - EX-32.1 - F-star Therapeutics, Inc. | sbph-ex321_8.htm |
| EX-31.2 - EX-31.2 - F-star Therapeutics, Inc. | sbph-ex312_11.htm |
| EX-31.1 - EX-31.1 - F-star Therapeutics, Inc. | sbph-ex311_10.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Nos. 333-212047, 333-218399) on Form S-3 and Registration Statement (No. 333-212047) on Form S-8 of our report dated February 20, 2018 relating to the consolidated financial statements of Spring Bank Pharmaceuticals, Inc. and its subsidiaries, appearing in this Annual Report on Form 10-K of Spring Bank Pharmaceuticals, Inc. for the year ended December 31, 2017.
/s/ RSM US LLP
Boston, Massachusetts
February 20, 2018